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Tetanus and use of magnesium in resource
limited country
A. Basher
Mymensingh Medical College Hospital, Mymensingh,
Bangladesh
Background: Tetanus is a nervous system disorder charac-
terized by muscle spasms that is caused by the toxin-producing
anaerobe, Clostridium Tetani. It is almost obsolete disease in devel-
oped country but one of the most neglected diseases in developing
country.
Methods & Materials: Case series, Here we describe the 320
cases of diagnosed tetanus cases admitted in Infectious unit of
Mymensingh Medical college Hospital during the period of 3 year
from July2011 to July 2014.
Results: Median age of the patient was 40(R-3-70) years and
264(82.5%) were male; outnumbered were female. Most 95%(304)
patients were from rural area and 65%(208) had family income
around100US$/month. Clinical pictures revealedalmost all (95.7%)
had lock jaw, pain in the neck and back. About 47.8% patinets
had resus sardonicus and 28% had opisthotonus. 87% had both
upper and lower limb spasticity. One hundred twenty four (38.75%)
had history of wound in lower limb, 21.6% (69)had upper limb
and 20 had history of CSOM, 10 had incomplete abortion, 16 had
due to surgical complication. Large number of patients(81) failed
to reveal any causative factor. Incubation period between wound
and tetanus developed from 6-90 days. Inj. TT and TIG(1500 to
3000IU) was given intramuscularly as a single dose in all patients.
All patients were treated with Inj. Metronidazole and occasion-
ally with other add in antibiotics. Spasm was mostly controlled
by continuous infusion of Inj. Diazepam ranging from 30mg to
100mg/day . Inj Magnesium sulphate heptahydrate BP 4% w/v in
100ml i.v. solution was used 8 hourly as an additional therapy for
control convulsion. Parenteral feeding followed by late oral feed-
ing was given to maintain nutrition. Sixtysix (20%) patient died
mostly due to lack of ICU support , 15 recovered with sequele .
Most of the patients (75%) died within 3 days of treatment(R-1-
15days). Most patients(87%) had lack a history of receipt of full
series of tetanus toxoid immunization and inadequate prophylaxis
following a wound.
Conclusion: Low dose of magnesium is a good choice for treat-
ment of tetanus; where modern logistic support is almost nills.
Prevention of tetanus is a real priority subject in our community
health.
http://dx.doi.org/10.1016/j.ijid.2016.02.608
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Background: The chronic infections are often caused by
pathogens that are susceptible to antibiotics. Existing antimicro-
bial therapies are not able to treat or eradicate chronic infections.
Recent studies show that treatments for chronic infections are
failed due to small subpopulation of microbial cells, called per-
sister cells. Persister cells have ability to survive even at lethal
dose of antibiotics known as multidrug tolerance. The molecular
mechanism of persister cell formation is unknown and not well
understood but it is well established that toxin-antitoxin systems
play a key role in the formation of same. Currently available ther-
apeutic suppress, but do not eradicate the infection completely.
An effective method for their eradication is great interests to
researchers. We found three gene loci in the genome of Pseu-
domonas aeruginosa codes for toxin-antitoxin proteins. Certain
metabolites if given in combination of antibiotics, they can treat
persister cells more efﬁciently. The identiﬁcation and evaluation of
toxin-antitoxin genes can provide a clue to develop new strategies
for treating pathogens. The study of various metabolites effects in
combination with antibiotics on persister cell can lead to develop-
ment of new antipersister therapy for treating chronic and latent
infections.
Methods & Materials: Persister Cell Assay (Antibiotic based):
Culture of P. aeruginosa, ampicillin & LB-Agar. Persister Cell Assay
(Green ﬂuorescent protein based): Arabinose inducible green ﬂu-
orescentprotein containingvector.Protein-ProteinBlast:Putative
toxin-antitoxins operon from the genome of P. aeruginosa using
NCBI server. (http://blast.ncbi.nlm.nih.gov/Blast.cgi) Phylogenetic
Analysis: Different annotated protein sequences were multiple
aligned and phylogenetic trees were constructed by using CLC
Genomics Workbench (version 5.5 software).
Results: Please ﬁnd attachments
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Conclusion: This experiment revealed a small subpopulation
of cells that remain alive irrespective of concentration of antimi-
crobial agents. In exponential phase the number of persister cell
was low than stationary growth phase populations. In addition, the
persister cells of P. aeruginosa exhibit a high tolerance to the vari-
ety of antibiotics, and phenotype was not inherited as tested with
four passages of P. aeruginosapopulations. In-silico results show the
presence of parDE, relBE, and higBA toxin-antitoxin systems among
which ParE toxin generates double strand breaks while RelE & HigB
toxins induce mRNA cleavage.
http://dx.doi.org/10.1016/j.ijid.2016.02.609
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Impact of antimicrobial stewardship in
collaboration with infection control on
hospital-acquired infection rates in a
subspecialty cancer treatment facility
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Background: Antimicrobial stewardship programs (ASP) in col-
laboration with infection control have been shown to reduce rates
of hospital-acquired infections (HAI) and prevent development of
resistant organisms. ASP ensures the medical staff is appropriately
educated on protocols developed by infection control and moni-
tors the use of antibiotics to reduce the risk of C. difﬁcile and other
multi-drug- resistant organisms. These services are imperative in
hematology/oncology patients who are at elevated risk for acquir-
ing HAIs due to immunosuppression, chronic intravenous access,
and frequent hospitalizations. We sought to determine if ASP in
combination with infection control could reduce HAIs in a subspe-
cialty oncology hospital.
Methods & Materials: We performed a retrospective review of
HAIs between January 2012 and September 2015. Antimicrobial
usage from July 2011 through September 2015 and antimicrobial
susceptibility data from December 2010 through November 2014
was collected. During this time, ASP and infection control strategies
included: nursing education on appropriate methods of accessing
ports andmanagement of foley catheters, adherence to strict hand-
hygiene protocols, consultation by the infectious disease physician,
anddaily reviewof all patients on antimicrobial agents by the infec-
tious disease pharmacist.
Results: In a 74-bed subspecialty cancer treatment facility
with oncology and stem cell transplant patients, ASP was estab-
lished in 2012. Since inception, the rate of central line-associated
blood stream infections (CLABSI) steadily declined and was main-
tained below the national pooled mean since May 2013 (Figure 1).
Additionally, no incidences of CLABSIs were reported for 1 year
(January 2014 through February 2015). Due to the low usage of
meropenem and imipenem (24 and 29 days of therapy per 1,000
patient days respectively) between August 2011 and September
2015, there have been only 3.2 isolates per 1,000 patient days
identiﬁed of Carbapenem-resistant Enterobacteriaceae. Additionally,
rates of HAIMRSA and C. difﬁcile remained extremely low (0.18 and
0.2 infections per 1,000 patient days, respectively) after ASP was
implemented.
Conclusion: Through education, implementation of speciﬁc
protocols, and ASP interventions, the risk of hospitalized hematol-
